💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
|
🏷️ 产品编码
RB9T37014655
|
🧬 中文名称
Glofitamab ELISA试剂盒(靶标:)
|
|
📝 英文名称
Glofitamab ELISA Kit
| |
|
🔬 应用
ELISA
| |
|
🔢 登录号
P11836 & P07766
|
🔹 检测方法
Colorimetric
|
|
🔹 灵敏度
0.156 μg/ml
|
🔹 检测范围
0.31-5 μg/mL
|
|
🔹 回收率
80-120%
|
🔹 样本类型
Plasma, Serum
|
|
🔹 检测类型
Quantitative
|
🔹 背景信息
Glofitamab (RG6026) is a novel T-cell-engaging, bispecific antibody that binds bivalently to CD20 on B cells, and monovalently to CD3 on T cells. In study NP30179 (NCT03075696), an ongoing Phase I/II dose-escalation and expansion study, glofitamab fixed-dosing (0.6-25mg) with obinutuzumab pre-treatment (Gpt) achieved high, durable CRs with manageable safety in pts with heavily pre-treated R/R NHL (Dickinson et al. EHA 2020). Step-up dosing (SUD) of glofitamab, in addition to Gpt, allowed dose-escalation up to the highest planned dose of 30mg to maximize efficacy, while mitigating cytokine release syndrome (CRS; [Hutchings et al. J Clin Oncol 2021]). We present updated duration of response (DoR) data from the glofitamab monotherapy fixed-dosing and SUD cohorts of study NP30179 in pts with R/R NHL.
|
|
🏷️ 别名
CD20-TCB (2:1), RG-6026, 2229047-91-8
| |
❄️ 稳定性和储存
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
🚚 运输条件
2-8 ℃
⚠️ For Research Use Only.